Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 473

1.

The MINDVIEW project: First results.

Benlloch JM, González AJ, Pani R, Preziosi E, Jackson C, Murphy J, Barberá J, Correcher C, Aussenhofer S, Gareis D, Visvikis D, Bert J, Langstrom B, Farde L, Toth M, Haggkvist J, Caixeta FV, Kullander K, Somlai-Schweiger I, Schwaiger M.

Eur Psychiatry. 2018 Apr;50:21-27. doi: 10.1016/j.eurpsy.2018.01.002. Epub 2018 Feb 2.

PMID:
29398564
2.

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening.

Kumar R, Kumar A, Långström B, Darreh-Shori T.

Sci Rep. 2017 Nov 24;7(1):16287. doi: 10.1038/s41598-017-16033-w.

3.

Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers: Insight from Molecular Modeling Studies.

Balamurugan K, Murugan NA, Långström B, Nordberg A, Ågren H.

ACS Chem Neurosci. 2017 Dec 20;8(12):2655-2666. doi: 10.1021/acschemneuro.7b00215. Epub 2017 Oct 3.

PMID:
28898051
4.

Development of [11C]/[3H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand.

Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, Furumoto S, Mitsios N, Mulder J, Långström B, Nordberg A, Halldin C.

Nucl Med Biol. 2017 Mar;46:50-53. doi: 10.1016/j.nucmedbio.2016.12.004. Epub 2016 Dec 9.

PMID:
28013122
5.

Theoretical study of the binding profile of an allosteric modulator NS-1738 with a chimera structure of the α7 nicotinic acetylcholine receptor.

Kuang G, Wang X, Halldin C, Nordberg A, Långström B, Ågren H, Tu Y.

Phys Chem Chem Phys. 2016 Oct 12;18(40):28003-28009.

PMID:
27711412
6.

Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.

Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A.

Alzheimers Dement. 2017 Apr;13(4):419-430. doi: 10.1016/j.jalz.2016.08.006. Epub 2016 Sep 28.

PMID:
27693181
7.

Decreased Brain Neurokinin-1 Receptor Availability in Chronic Tennis Elbow.

Linnman C, Catana C, Svärdsudd K, Appel L, Engler H, Långström B, Sörensen J, Furmark T, Fredrikson M, Borsook D, Peterson M.

PLoS One. 2016 Sep 22;11(9):e0161563. doi: 10.1371/journal.pone.0161563. eCollection 2016.

8.

Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.

Frick A, Åhs F, Appel L, Jonasson M, Wahlstedt K, Bani M, Merlo Pich E, Bettica P, Långström B, Lubberink M, Fredrikson M, Furmark T.

Eur Neuropsychopharmacol. 2016 Nov;26(11):1775-1783. doi: 10.1016/j.euroneuro.2016.09.004. Epub 2016 Sep 15.

PMID:
27642077
9.

Women with Premenstrual Dysphoria Lack the Seemingly Normal Premenstrual Right-Sided Relative Dominance of 5-HTP-Derived Serotonergic Activity in the Dorsolateral Prefrontal Cortices - A Possible Cause of Disabling Mood Symptoms.

Eriksson O, Wall A, Olsson U, Marteinsdottir I, Holstad M, Ågren H, Hartvig P, Långström B, Naessén T.

PLoS One. 2016 Sep 12;11(9):e0159538. doi: 10.1371/journal.pone.0159538. eCollection 2016.

10.

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization.

Kumar R, Långström B, Darreh-Shori T.

Sci Rep. 2016 Aug 10;6:31247. doi: 10.1038/srep31247.

11.

The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid-Specific Tracers.

Murugan NA, Halldin C, Nordberg A, Långström B, Ågren H.

J Phys Chem Lett. 2016 Sep 1;7(17):3313-21. doi: 10.1021/acs.jpclett.6b01586. Epub 2016 Aug 12.

PMID:
27498616
12.

Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder.

Furmark T, Marteinsdottir I, Frick A, Heurling K, Tillfors M, Appel L, Antoni G, Hartvig P, Fischer H, Långström B, Eriksson E, Fredrikson M.

J Psychopharmacol. 2016 Oct;30(10):1028-35. doi: 10.1177/0269881116648317. Epub 2016 May 17.

PMID:
27189957
13.

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.

Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A.

J Nucl Med. 2016 Jul;57(7):1071-7. doi: 10.2967/jnumed.115.168732. Epub 2016 Feb 16.

14.

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.

Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A.

Brain. 2016 Mar;139(Pt 3):922-36. doi: 10.1093/brain/awv404. Epub 2016 Jan 26.

15.

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.

Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A.

Sci Rep. 2015 Nov 10;5:16404. doi: 10.1038/srep16404.

16.

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.

Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.

J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.

PMID:
26401704
17.

Synthesis of ([(11)C]carbonyl)raclopride and a comparison with ([(11)C]methyl)raclopride in a monkey PET study.

Rahman O, Takano A, Amini N, Dahl K, Kanegawa N, Långström B, Farde L, Halldin C.

Nucl Med Biol. 2015 Nov;42(11):893-8. doi: 10.1016/j.nucmedbio.2015.07.003. Epub 2015 Jul 15.

PMID:
26272268
18.

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.

Frick A, Ahs F, Linnman C, Jonasson M, Appel L, Lubberink M, Långström B, Fredrikson M, Furmark T.

Transl Psychiatry. 2015 Jul 7;5:e597. doi: 10.1038/tp.2015.92.

19.

Endogenous compounds labeled with radionuclides of short half-life-some perspectives.

Långström B, Karimi F, Watanabe Y.

J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):251-62. doi: 10.1002/jlcr.3033. Review.

PMID:
24285332
20.

Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET.

Appel L, Bergström M, Buus Lassen J, Långström B.

Eur Neuropsychopharmacol. 2014 Feb;24(2):251-61. doi: 10.1016/j.euroneuro.2013.10.007. Epub 2013 Oct 22.

PMID:
24239329

Supplemental Content

Loading ...
Support Center